Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Receivables - Net (2012 - 2026)

Exelixis (EXEL) posted quarterly Receivables - Net of $328.9 million for Q2 2026, up 16.8% year-over-year from $281.6 million in Q2 2025, and up 14.65% quarter-over-quarter from $286.9 million in Q1 2026.

Analysis

Exelixis (EXEL) Receivables - Net (2012 - 2026) Analysis & Trends

Exelixis' Receivables - Net history runs 15 years deep, the most recent figure standing at $328.9 million for Q2 2026.

  • In Q2 2026, Receivables - Net rose 16.8% year-over-year to $328.9 million; the TTM figure through Apr 2026 stood at $328.9 million (up 16.8% YoY), while the FY2026 annual figure was $286.9 million, up 8.09% from the prior year.
  • Receivables - Net for Q2 2026 stood at $328.9 million, up from $286.9 million in the prior quarter.
  • The five-year high for Receivables - Net was $396.6 million in Q2 2024, with the low at $190.6 million in Q2 2022.
  • The 5-year median for Receivables - Net is $248.1 million (2023), against an average of $263.5 million.
  • The sharpest annual moves came in 2024 and 2025: Receivables - Net soared 70.34% in 2024, then decreased 26.28% in 2025.
  • Exelixis' Receivables - Net stood at $214.8 million in 2022, then grew by 10.53% to $237.4 million in 2023, then advanced by 13.6% to $269.7 million in 2024, then advanced by 14.84% to $309.7 million in 2025, then gained by 6.21% to $328.9 million in 2026.
  • Business Quant data shows EXEL's Receivables - Net at $328.9 million in Q2 2026, $286.9 million in Q1 2026, and $309.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 322.21 Mn
Apr 3, 2026 328.95 Mn
Jan 2, 2026 286.92 Mn
Oct 3, 2025 309.73 Mn
Jul 4, 2025 292.35 Mn
Apr 4, 2025 281.64 Mn
Jan 3, 2025 265.44 Mn
Sep 27, 2024 269.71 Mn
Jun 28, 2024 396.58 Mn
Mar 29, 2024 240.58 Mn
Dec 29, 2023 237.41 Mn
Sep 29, 2023 248.11 Mn
Jun 30, 2023 232.82 Mn
Mar 31, 2023 233.92 Mn
Dec 30, 2022 214.78 Mn
Sep 30, 2022 215.02 Mn
Jul 1, 2022 235.40 Mn
Apr 1, 2022 190.61 Mn
Dec 31, 2021 282.65 Mn
Oct 1, 2021 179.49 Mn